RGRX...16...Bullish Harami Cross Reversal Pattern formed to the Upside as the Bollies start to Squeeze...
RGRX...Looking for RGRX to Break the .16/.20 Consolidation Channel to the Upside and make a run at the previous high of .82 should they have positive news from the FDA meeting...imo...we shall see...
Will be adding more for the February FDA meeting...
ROCKVILLE, Md., Dec. 17, 2021 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the U.S. FDA has accepted its request for a pre-BLA meeting pursuant to RGN-259, its novel product candidate for dry eye syndrome. The meeting is scheduled for February 28, 2022. A BLA (Biologics License Application) is FDA's standard "full approval" mechanism for biological products, including therapeutics and vaccines.